The study aims to explore the relationship between serum 1,5-AG and time in range in assessing diabetic retinopathy risk for type 2 diabetes patients.
Analyzed serum 1,5-AG levels
Evaluated time in range (TIR) as a relevant metric
Examined the prevalence of diabetic retinopathy in patients
Higher serum 1,5-AG levels were associated with increased prevalence of diabetic retinopathy.
Patients with a time in range of 80% or more showed additional risk indicators for diabetic retinopathy.
Abstract
Serum 1,5-AG is significantly associated with the prevalence of DR in type 2 diabetes. For patients with TIR ≥ 80%, 1,5-AG may reveal additional risk of DR.